Click for best price
Transmucosal Drug Delivery Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Transmucosal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transmucosal Drug Delivery. This report contains market size and forecasts of Transmucosal Drug Delivery in global, including the following market information:
Global Transmucosal Drug Delivery Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Transmucosal Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Passive Transdermal Drug Delivery Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transmucosal Drug Delivery include 3M Pharmaceuticals, Acrux Limited, ALZA Corporation, Antares Pharma, Inc., Apricus BioSciences, Inc, Aveva Drug Delivery Systems, Corium International, Inc, DURECT Corporation and Generex Biotechnology Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transmucosal Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transmucosal Drug Delivery Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Transmucosal Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery
Global Transmucosal Drug Delivery Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Transmucosal Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Transmucosal Drug Delivery Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Transmucosal Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transmucosal Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Transmucosal Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transmucosal Drug Delivery, market overview.
Chapter 2: Global Transmucosal Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Transmucosal Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transmucosal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Transmucosal Drug Delivery Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Transmucosal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transmucosal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transmucosal Drug Delivery Overall Market Size
2.1 Global Transmucosal Drug Delivery Market Size: 2022 VS 2030
2.2 Global Transmucosal Drug Delivery Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transmucosal Drug Delivery Players in Global Market
3.2 Top Global Transmucosal Drug Delivery Companies Ranked by Revenue
3.3 Global Transmucosal Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Transmucosal Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Transmucosal Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transmucosal Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Transmucosal Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Transmucosal Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Transmucosal Drug Delivery Market Size Markets, 2022 & 2030
4.1.2 Passive Transdermal Drug Delivery
4.1.3 Active Transdermal Drug Delivery
4.2 By Type - Global Transmucosal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Transmucosal Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Transmucosal Drug Delivery Revenue, 2024-2030
4.2.3 By Type - Global Transmucosal Drug Delivery Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transmucosal Drug Delivery Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Transmucosal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Transmucosal Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Transmucosal Drug Delivery Revenue, 2024-2030
5.2.3 By Application - Global Transmucosal Drug Delivery Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Transmucosal Drug Delivery Market Size, 2022 & 2030
6.2 By Region - Global Transmucosal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Transmucosal Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Transmucosal Drug Delivery Revenue, 2024-2030
6.2.3 By Region - Global Transmucosal Drug Delivery Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Transmucosal Drug Delivery Revenue, 2018-2030
6.3.2 US Transmucosal Drug Delivery Market Size, 2018-2030
6.3.3 Canada Transmucosal Drug Delivery Market Size, 2018-2030
6.3.4 Mexico Transmucosal Drug Delivery Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Transmucosal Drug Delivery Revenue, 2018-2030
6.4.2 Germany Transmucosal Drug Delivery Market Size, 2018-2030
6.4.3 France Transmucosal Drug Delivery Market Size, 2018-2030
6.4.4 U.K. Transmucosal Drug Delivery Market Size, 2018-2030
6.4.5 Italy Transmucosal Drug Delivery Market Size, 2018-2030
6.4.6 Russia Transmucosal Drug Delivery Market Size, 2018-2030
6.4.7 Nordic Countries Transmucosal Drug Delivery Market Size, 2018-2030
6.4.8 Benelux Transmucosal Drug Delivery Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Transmucosal Drug Delivery Revenue, 2018-2030
6.5.2 China Transmucosal Drug Delivery Market Size, 2018-2030
6.5.3 Japan Transmucosal Drug Delivery Market Size, 2018-2030
6.5.4 South Korea Transmucosal Drug Delivery Market Size, 2018-2030
6.5.5 Southeast Asia Transmucosal Drug Delivery Market Size, 2018-2030
6.5.6 India Transmucosal Drug Delivery Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Transmucosal Drug Delivery Revenue, 2018-2030
6.6.2 Brazil Transmucosal Drug Delivery Market Size, 2018-2030
6.6.3 Argentina Transmucosal Drug Delivery Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, 2018-2030
6.7.2 Turkey Transmucosal Drug Delivery Market Size, 2018-2030
6.7.3 Israel Transmucosal Drug Delivery Market Size, 2018-2030
6.7.4 Saudi Arabia Transmucosal Drug Delivery Market Size, 2018-2030
6.7.5 UAE Transmucosal Drug Delivery Market Size, 2018-2030
7 Transmucosal Drug Delivery Companies Profiles
7.1 3M Pharmaceuticals
7.1.1 3M Pharmaceuticals Company Summary
7.1.2 3M Pharmaceuticals Business Overview
7.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Major Product Offerings
7.1.4 3M Pharmaceuticals Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 3M Pharmaceuticals Key News & Latest Developments
7.2 Acrux Limited
7.2.1 Acrux Limited Company Summary
7.2.2 Acrux Limited Business Overview
7.2.3 Acrux Limited Transmucosal Drug Delivery Major Product Offerings
7.2.4 Acrux Limited Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Acrux Limited Key News & Latest Developments
7.3 ALZA Corporation
7.3.1 ALZA Corporation Company Summary
7.3.2 ALZA Corporation Business Overview
7.3.3 ALZA Corporation Transmucosal Drug Delivery Major Product Offerings
7.3.4 ALZA Corporation Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 ALZA Corporation Key News & Latest Developments
7.4 Antares Pharma, Inc.
7.4.1 Antares Pharma, Inc. Company Summary
7.4.2 Antares Pharma, Inc. Business Overview
7.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Major Product Offerings
7.4.4 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Antares Pharma, Inc. Key News & Latest Developments
7.5 Apricus BioSciences, Inc
7.5.1 Apricus BioSciences, Inc Company Summary
7.5.2 Apricus BioSciences, Inc Business Overview
7.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Major Product Offerings
7.5.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 Apricus BioSciences, Inc Key News & Latest Developments
7.6 Aveva Drug Delivery Systems
7.6.1 Aveva Drug Delivery Systems Company Summary
7.6.2 Aveva Drug Delivery Systems Business Overview
7.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Major Product Offerings
7.6.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 Aveva Drug Delivery Systems Key News & Latest Developments
7.7 Corium International, Inc
7.7.1 Corium International, Inc Company Summary
7.7.2 Corium International, Inc Business Overview
7.7.3 Corium International, Inc Transmucosal Drug Delivery Major Product Offerings
7.7.4 Corium International, Inc Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Corium International, Inc Key News & Latest Developments
7.8 DURECT Corporation
7.8.1 DURECT Corporation Company Summary
7.8.2 DURECT Corporation Business Overview
7.8.3 DURECT Corporation Transmucosal Drug Delivery Major Product Offerings
7.8.4 DURECT Corporation Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 DURECT Corporation Key News & Latest Developments
7.9 Generex Biotechnology Corporation
7.9.1 Generex Biotechnology Corporation Company Summary
7.9.2 Generex Biotechnology Corporation Business Overview
7.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Major Product Offerings
7.9.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 Generex Biotechnology Corporation Key News & Latest Developments
7.10 Inovio Pharmaceuticals, Inc.
7.10.1 Inovio Pharmaceuticals, Inc. Company Summary
7.10.2 Inovio Pharmaceuticals, Inc. Business Overview
7.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Major Product Offerings
7.10.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 Inovio Pharmaceuticals, Inc. Key News & Latest Developments
7.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
7.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Summary
7.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
7.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Major Product Offerings
7.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Key News & Latest Developments
7.12 MedPharm LTD
7.12.1 MedPharm LTD Company Summary
7.12.2 MedPharm LTD Business Overview
7.12.3 MedPharm LTD Transmucosal Drug Delivery Major Product Offerings
7.12.4 MedPharm LTD Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.12.5 MedPharm LTD Key News & Latest Developments
7.13 Mylan, Inc.
7.13.1 Mylan, Inc. Company Summary
7.13.2 Mylan, Inc. Business Overview
7.13.3 Mylan, Inc. Transmucosal Drug Delivery Major Product Offerings
7.13.4 Mylan, Inc. Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.13.5 Mylan, Inc. Key News & Latest Developments
7.14 Nemaura Pharma Ltd
7.14.1 Nemaura Pharma Ltd Company Summary
7.14.2 Nemaura Pharma Ltd Business Overview
7.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Major Product Offerings
7.14.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.14.5 Nemaura Pharma Ltd Key News & Latest Developments
7.15 Nitto Denko Corporation
7.15.1 Nitto Denko Corporation Company Summary
7.15.2 Nitto Denko Corporation Business Overview
7.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Major Product Offerings
7.15.4 Nitto Denko Corporation Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.15.5 Nitto Denko Corporation Key News & Latest Developments
7.16 Noven Pharmaceuticals, Inc.
7.16.1 Noven Pharmaceuticals, Inc. Company Summary
7.16.2 Noven Pharmaceuticals, Inc. Business Overview
7.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Major Product Offerings
7.16.4 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.16.5 Noven Pharmaceuticals, Inc. Key News & Latest Developments
7.17 Pantec Biosolutions AG
7.17.1 Pantec Biosolutions AG Company Summary
7.17.2 Pantec Biosolutions AG Business Overview
7.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Major Product Offerings
7.17.4 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.17.5 Pantec Biosolutions AG Key News & Latest Developments
7.18 Tapemark
7.18.1 Tapemark Company Summary
7.18.2 Tapemark Business Overview
7.18.3 Tapemark Transmucosal Drug Delivery Major Product Offerings
7.18.4 Tapemark Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.18.5 Tapemark Key News & Latest Developments
7.19 tesa Labtec GmbH
7.19.1 tesa Labtec GmbH Company Summary
7.19.2 tesa Labtec GmbH Business Overview
7.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Major Product Offerings
7.19.4 tesa Labtec GmbH Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.19.5 tesa Labtec GmbH Key News & Latest Developments
7.20 TEVA Pharmaceutical Industries Ltd.
7.20.1 TEVA Pharmaceutical Industries Ltd. Company Summary
7.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
7.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Major Product Offerings
7.20.4 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.20.5 TEVA Pharmaceutical Industries Ltd. Key News & Latest Developments
7.21 Zosano Pharma
7.21.1 Zosano Pharma Company Summary
7.21.2 Zosano Pharma Business Overview
7.21.3 Zosano Pharma Transmucosal Drug Delivery Major Product Offerings
7.21.4 Zosano Pharma Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.21.5 Zosano Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Transmucosal Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Transmucosal Drug Delivery Market Drivers in Global Market
Table 3. Transmucosal Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Transmucosal Drug Delivery in Global Market
Table 5. Top Transmucosal Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Transmucosal Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Transmucosal Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Transmucosal Drug Delivery Product Type
Table 9. List of Global Tier 1 Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Transmucosal Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Transmucosal Drug Delivery Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 30. 3M Pharmaceuticals Company Summary
Table 31. 3M Pharmaceuticals Transmucosal Drug Delivery Product Offerings
Table 32. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. 3M Pharmaceuticals Key News & Latest Developments
Table 34. Acrux Limited Company Summary
Table 35. Acrux Limited Transmucosal Drug Delivery Product Offerings
Table 36. Acrux Limited Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Acrux Limited Key News & Latest Developments
Table 38. ALZA Corporation Company Summary
Table 39. ALZA Corporation Transmucosal Drug Delivery Product Offerings
Table 40. ALZA Corporation Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. ALZA Corporation Key News & Latest Developments
Table 42. Antares Pharma, Inc. Company Summary
Table 43. Antares Pharma, Inc. Transmucosal Drug Delivery Product Offerings
Table 44. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. Antares Pharma, Inc. Key News & Latest Developments
Table 46. Apricus BioSciences, Inc Company Summary
Table 47. Apricus BioSciences, Inc Transmucosal Drug Delivery Product Offerings
Table 48. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. Apricus BioSciences, Inc Key News & Latest Developments
Table 50. Aveva Drug Delivery Systems Company Summary
Table 51. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Offerings
Table 52. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. Aveva Drug Delivery Systems Key News & Latest Developments
Table 54. Corium International, Inc Company Summary
Table 55. Corium International, Inc Transmucosal Drug Delivery Product Offerings
Table 56. Corium International, Inc Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Corium International, Inc Key News & Latest Developments
Table 58. DURECT Corporation Company Summary
Table 59. DURECT Corporation Transmucosal Drug Delivery Product Offerings
Table 60. DURECT Corporation Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. DURECT Corporation Key News & Latest Developments
Table 62. Generex Biotechnology Corporation Company Summary
Table 63. Generex Biotechnology Corporation Transmucosal Drug Delivery Product Offerings
Table 64. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 65. Generex Biotechnology Corporation Key News & Latest Developments
Table 66. Inovio Pharmaceuticals, Inc. Company Summary
Table 67. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offerings
Table 68. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 69. Inovio Pharmaceuticals, Inc. Key News & Latest Developments
Table 70. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Summary
Table 71. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Offerings
Table 72. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 73. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Key News & Latest Developments
Table 74. MedPharm LTD Company Summary
Table 75. MedPharm LTD Transmucosal Drug Delivery Product Offerings
Table 76. MedPharm LTD Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 77. MedPharm LTD Key News & Latest Developments
Table 78. Mylan, Inc. Company Summary
Table 79. Mylan, Inc. Transmucosal Drug Delivery Product Offerings
Table 80. Mylan, Inc. Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 81. Mylan, Inc. Key News & Latest Developments
Table 82. Nemaura Pharma Ltd Company Summary
Table 83. Nemaura Pharma Ltd Transmucosal Drug Delivery Product Offerings
Table 84. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 85. Nemaura Pharma Ltd Key News & Latest Developments
Table 86. Nitto Denko Corporation Company Summary
Table 87. Nitto Denko Corporation Transmucosal Drug Delivery Product Offerings
Table 88. Nitto Denko Corporation Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 89. Nitto Denko Corporation Key News & Latest Developments
Table 90. Noven Pharmaceuticals, Inc. Company Summary
Table 91. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offerings
Table 92. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 93. Noven Pharmaceuticals, Inc. Key News & Latest Developments
Table 94. Pantec Biosolutions AG Company Summary
Table 95. Pantec Biosolutions AG Transmucosal Drug Delivery Product Offerings
Table 96. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 97. Pantec Biosolutions AG Key News & Latest Developments
Table 98. Tapemark Company Summary
Table 99. Tapemark Transmucosal Drug Delivery Product Offerings
Table 100. Tapemark Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 101. Tapemark Key News & Latest Developments
Table 102. tesa Labtec GmbH Company Summary
Table 103. tesa Labtec GmbH Transmucosal Drug Delivery Product Offerings
Table 104. tesa Labtec GmbH Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 105. tesa Labtec GmbH Key News & Latest Developments
Table 106. TEVA Pharmaceutical Industries Ltd. Company Summary
Table 107. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product Offerings
Table 108. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 109. TEVA Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 110. Zosano Pharma Company Summary
Table 111. Zosano Pharma Transmucosal Drug Delivery Product Offerings
Table 112. Zosano Pharma Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 113. Zosano Pharma Key News & Latest Developments
List of Figures
Figure 1. Transmucosal Drug Delivery Segment by Type in 2022
Figure 2. Transmucosal Drug Delivery Segment by Application in 2022
Figure 3. Global Transmucosal Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transmucosal Drug Delivery Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Transmucosal Drug Delivery Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2022
Figure 8. By Type - Global Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 9. By Application - Global Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 10. By Type - Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 12. By Application - Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 14. By Region - Global Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 15. By Country - North America Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 16. US Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 20. Germany Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 21. France Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 28. China Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 32. India Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 34. Brazil Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Transmucosal Drug Delivery Revenue Market Share, 2018-2030
Figure 37. Turkey Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 41. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Acrux Limited Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. ALZA Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Corium International, Inc Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. DURECT Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. MedPharm LTD Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Mylan, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Nitto Denko Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Tapemark Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. tesa Labtec GmbH Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Zosano Pharma Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
